TheStreet
Eli Lilly’s pill solves the biggest problem with weight loss
📈
AI Sentiment
Highly Positive
10/10
Eli Lilly and Company News
Latest updates and market news for LLY
20 news
Dec 15 - Dec 21, 2025
Page 1
Benzinga
After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is It Too Late to Consider Eli Lilly After Its 568% Five Year Surge?
📊
AI Sentiment
Positive
6/10
Barrons.com
Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap.
📈
AI Sentiment
Highly Positive
8/10
GuruFocus.com
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
📊
AI Sentiment
Positive
7/10
Barrons.com
White House Cuts Drug-Pricing Deals With Pharma Companies, Tilting System Toward Self-Pay
➖
AI Sentiment
Neutral
4/10
Investor's Business Daily
Dow Jones Futures: Tech Stocks Eye Key Level; Oracle, Nike, FedEx In Focus
📊
AI Sentiment
Positive
7/10
Clinical Trials Arena
Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs
📈
AI Sentiment
Highly Positive
8/10
Barrons.com
Elanco CEO Bites Off More Shares of Fast-Rising Stock
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Eli Lilly (LLY) Gains Support From Daiwa and Goldman Sachs in Back-to-Back Calls
📈
AI Sentiment
Highly Positive
9/10
Zacks
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Eli Lilly, IBD Stock Of The Day, Proves The Merit Of Its Weight-Loss Pill
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Eli Lilly's Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Eli Lilly Says Orforglipron Helps Maintain Weight Loss After Switching From Injectable Incretins to Oral GLP-1 Therapy in Phase 3 Trial
📈
AI Sentiment
Highly Positive
8/10
Argus Research
Technical Assessment: Bullish in the Intermediate-Term
📈
AI Sentiment
Highly Positive
8/10
Share this news page